Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore ...

The Department of Health and Human Services is allegedly denying clinical trial funding for biotechs based on their ties to ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a ...

A clinical-stage biotech company based in Redwood City, California, developing tissue-restorative biologics for chronic ...

California-based clinical-stage biotech Juvena Therapeutics has entered a global licensing and multi-target research ...

Juvena Therapeutics & Eli Lilly and Company ink research collaboration focused on muscle health: Redwood City, California Saturday, June 14, 2025, 15:00 Hrs [IST] Juvena Therapeut ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Alector said it promoted Business Chief Neil Berkley as interim chief financial officer. Berkeley will succeed Marc Grasso, who gave notice of his decision to resign from the position to pursue ...

REDWOOD CITY, CA, USA I June 11, 2025 I Juvena Therapeutics, Inc. (“Juvena”), a clinical-stage biotechnology company pioneering tissue restorative biologics ...

Research will leverage world’s first AI-enabled screening platform for mapping the therapeutic potential of secreted signaling proteins, developed by Juvena Collaboration aims to accelerate the ...